Jan Mikkelsen

Mr. Jan M. Mikkelsen is a Chief Executive Officer & Director at Ascendis Pharma Endocrinology Division A/S, a President, CEO & Executive Director at Ascendis Pharma A/S, a Chief Executive Officer at Ascendis Pharma Bone Diseases A/S and a Chief Executive Officer at Ascendis Pharma Growth Disorders AS. He is on the Board of Directors at Ascendis Pharma Endocrinology Division A/S, Ascendis Pharma A/S and Visen Pharmaceuticals (Shanghai) Co. Ltd. Mr. Mikkelsen was previously employed as a President & Chief Executive Officer by LifeCycle Pharma A/S, a President-Pharmaceutical Division by Maxygen, Inc., a Co-Chief Executive Officer by Profound Pharma AS, and a Vice President-Protein Discovery by Novo Nordisk A/S. He received his undergraduate degree from the University of Southern Denmark.